Chunghwa Chemical Synthesis & Biotech Co., Ltd. (TPE:1762)

TPE:1762 Income Statement

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	977.79	1,347	2,086	2,117	1,935	1,544
Revenue Growth (YoY)	-35.52%	-35.42%	-1.45%	9.43%	25.34%	33.45%
Cost of Revenue	825.82	953.06	1,329	1,155	985.31	856.84
Gross Profit	151.97	394.32	757.31	961.76	949.39	686.75
Selling, General & Admin	151.09	182.14	233.8	271.78	239.89	202.1
Research & Development	184.12	205.84	242.7	244.79	252.67	215.73
Operating Expenses	335.22	387.98	476.5	498.23	510.91	417.83
Operating Income	-183.25	6.34	280.81	463.53	438.48	268.92
Interest Expense	-17.28	-21.13	-17.97	-9.68	-3.27	-4.76
Interest & Investment Income	8.06	8.65	8.25	4.51	0.18	0.42
Earnings From Equity Investments	47.83	44.87	36.51	51.1	50.1	37.9
Currency Exchange Gain (Loss)	0.3	23.64	6.88	56.82	-9.59	-11.82
Other Non Operating Income (Expenses)	7.72	9.68	8.25	8.13	18.45	8.51
EBT Excluding Unusual Items	-136.62	72.04	322.72	574.41	494.34	299.18
Gain (Loss) on Sale of Investments	6.57	-15.42	10.77	9.59	3.27	4.3
Gain (Loss) on Sale of Assets	0.61	0.61	-	-0.7	-	346.83
Other Unusual Items	0.03	-	-	-	-	-
Pretax Income	-129.41	57.22	333.49	583.31	497.61	650.3
Income Tax Expense	-26.45	4.19	68.58	117.17	96.56	118.23
Earnings From Continuing Operations	-102.95	53.03	264.91	466.14	401.05	532.06
Minority Interest in Earnings	-	-	-	-0.28	-0.27	-0.19
Net Income	-102.95	53.03	264.91	465.87	400.78	531.87
Net Income to Common	-102.95	53.03	264.91	465.87	400.78	531.87
Net Income Growth	-	-79.98%	-43.14%	16.24%	-24.65%	354.58%
Shares Outstanding (Basic)	39	56	78	78	78	78
Shares Outstanding (Diluted)	39	56	78	79	78	78
Shares Change (YoY)	-49.28%	-27.92%	-0.52%	0.23%	-0.02%	0.16%
EPS (Basic)	-2.61	0.95	3.42	6.01	5.17	6.86
EPS (Diluted)	-2.61	0.94	3.39	5.93	5.12	6.79
EPS Growth	-	-72.27%	-42.83%	15.82%	-24.59%	352.67%
Free Cash Flow	293.02	364.57	-516.27	359.12	-184.18	-53.38
Free Cash Flow Per Share	7.43	6.48	-6.61	4.58	-2.35	-0.68
Dividend Per Share	0.192	0.192	0.800	1.300	1.300	1.500
Dividend Growth	-76.05%	-76.05%	-38.46%	-	-13.33%	87.50%
Gross Margin	15.54%	29.27%	36.30%	45.43%	49.07%	44.49%
Operating Margin	-18.74%	0.47%	13.46%	21.89%	22.66%	17.42%
Profit Margin	-10.53%	3.94%	12.70%	22.00%	20.71%	34.46%
Free Cash Flow Margin	29.97%	27.06%	-24.74%	16.96%	-9.52%	-3.46%
EBITDA	10.5	205.5	473.81	632.58	570.47	400.07
EBITDA Margin	1.07%	15.25%	22.71%	29.88%	29.49%	25.92%
D&A For EBITDA	193.75	199.16	193.01	169.05	131.99	131.15
EBIT	-183.25	6.34	280.81	463.53	438.48	268.92
EBIT Margin	-18.74%	0.47%	13.46%	21.89%	22.66%	17.42%
Effective Tax Rate	-	7.32%	20.56%	20.09%	19.41%	18.18%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.